5-HT3B Products

Antibodies
5-HT3B Antibody
5-HT3B Antibody
NBP1-90316
Species: Hu
Applications: IHC, IHC-P
Host: Rabbit Polyclonal
5-HT3B Antibody
5-HT3B Antibody
NBP1-51969
Species: Hu
Applications: WB, PEP-ELISA
Host: Goat Polyclonal
5-HT3B Antibody
5-HT3B Antibody
H00009177-B01P
Species: Hu
Applications: WB, ELISA
Host: Mouse Polyclonal
Lysates
5-HT3B Overexpression Lysate ...
5-HT3B Overexpression Lysate (Dena...
H00009177-T01
Species: Hu
Applications: WB
Proteins
5-HT3B Recombinant Protein An ...
5-HT3B Recombinant Protein Antigen
NBP1-90316PEP
Species: Hu
Applications: AC
5-HT3B Recombinant Protein
5-HT3B Recombinant Protein
H00009177-G01
Species: Hu
RNAi
5-HT3B RNAi
5-HT3B RNAi
H00009177-R01
Species: Hu
Applications: RNAi, RNAi SP

Description

The product of the HT3B belongs to the ligand-gated ion channel receptor superfamily. This gene encodes subunit B of the type 3 receptor for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. This receptor causes fast, depolarizing responses in neurons after activation. It appears that the heteromeric combination of A and B subunits is necessary to provide the full functional features of this receptor, since either subunit alone results in receptors with very low conductance and response amplitude. (provided by RefSeq)

Bioinformatics

Entrez Human
Uniprot Human
Product By Gene ID 9177
Alternate Names
  • 5-HT3-B
  • serotonin-gated ion channel subunit
  • Serotonin receptor 3B
  • 5-HT3B5-hydroxytryptamine receptor 3B
  • 5-hydroxytryptamine 3 receptor B subunit
  • 5-hydroxytryptamine (serotonin) receptor 3B

Pathways for 5-HT3B

View related products by pathway and learn more about each of the pathways below.

Pathogenesis
Transport
Bioluminescence
Response To Clozapine
Peristalsis
Cognition

Bioinformatics Tool for 5-HT3B

Discover related pathways, diseases and genes to 5-HT3B. Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
 
Vizit™, under license from BioVista Inc.